Add Bulwark+ Takes feed to your player of choice, here.
Over the last 12 months, PanCAN stood in strong opposition to the administration’s threats to severely reduce federal funding ...
Despite another quarter of declining sales for Ibrance, its top-selling oncology drug, revenue for Pfizer's overall oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results